A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling itHealthradar23. Oktober 2025 A near-death experience with hemorrhage left a scientist searching for ways to detect serious blood loss early. Kelsey Mayo was…
Health Seae Ventures acquires Unseen Capital after founder deathHealthradar1. Juni 2025 Seae Ventures is acquiring Unseen Capital after the death of founder Kayode Owens in 2021. The combined firm will continue…
Health This founder was worried about his mother slipping — so he created sensors to detect fallsHealthradar31. Mai 2025 Falls are common for older people living semi-independently. According to the Centers for Disease Control and Prevention (CDC), they’re the…
